You searched for "patient"

4205 results found

Eye Capacity: clinical need should drive ophthalmic service provision

Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

Laissez-faire approach for medial canthus tumours

This is a retrospective comparative case series of patients who underwent reconstruction of a medial canthal defect using laissez-faire approach (LFS), or a full-thickness skin graft (FTSG). The surgical options were discussed with the patient and the treatment decision was...

MR- vs. LR+ for divergence insufficiency

A retrospective study was conducted to compare the efficacy of medial rectus recession and lateral rectus resection as surgical interventions for divergence insufficiency in 18 patients. These were cases of non-neurological cause. Two patients in each group required postoperative adjustment....

Cyanoacrylate vs. fibrin glue

This study compared the safety and efficacy of fibrin and cyanoacrylate glue for refixating the recessed muscle to the sclera in patients undergoing strabismus surgery. The fibrin group (a) included 21 eyes of 15 patients; mean age of 11.6 ±7.49...

Prostaglandin associated periorbitopathy

Prostaglandins are known to cause periorbital adverse effects. The aim of this retrospective case series was to compare the frequency of prostaglandin associated periorbitopathy (PAP) between bimatoprost, latanoprost and travoprost users. Five PAP findings were evaluated: upper lid ptosis, deepening...

Acanthamoeba keratitis

This is a retrospective case series on medical records and corneal photographs of 40 eyes of 35 patients with acanthamoeba keratitis (AK, culture positive or with histopathological diagnosis). The mean age of onset was 30 ±15 years (younger in females)....

Risk factors for visual impairment in facial nerve palsy

Facial nerve palsy (FNP) is known to be associated with corneal exposure due to the nature of the condition, but how many of those will go on to develop severe visual impairment (SVI)? This study investigates the risk factors associated...

Sustainability in ophthalmic imaging

Sustainability has become more significant across all areas within healthcare as organisations aim to lower environmental impact whilst maintaining high standards of patient care. Ophthalmology is a technologically advanced specialty with regular equipment upgrades, and ophthalmic imaging plays a significant...

Revolutionising eyecare: Gloucestershire’s Community Ophthalmic Link delivers nationally significant results

Ophthalmology is the largest outpatient specialty in the NHS, and in Gloucestershire, it is growing at an annual rate of 2.55%, outpacing other specialties. However, rising demand has led to significant waiting lists, often resulting in patients not being seen...

Eye drop prescription and usage in glaucoma patients

The authors describe a study using a questionnaire to determine how patients use their glaucoma medications to investigate the association between patterns of eye drop prescriptions and medication use. They enrolled 67 Japanese patients who had been prescribed topical anti-glaucoma...

The College of Optometrists welcomes Healthwatch England's primary eye care report recommendations

The College of Optometrists welcomes Healthwatch England’s recommendations to commission more optometry services within primary care to reduce hospital waiting times and improve patient outcomes Professor Irene Ctori FCOptom, Vice-President of The College of Optometrists, commented: “Healthwatch England’s new report...

Fingolimod: ocular adverse effects

In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....